More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Eylea (aflibercept 8mg, 114.3 ...

Age related macular degeneration is diagnosed through eye examination. Ophthalmologists use retinal imaging and optical ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

The MHRA has granted marketing authorisation for Eylea® (aflibercept 8 mg) for the treatment of patients with macular oedema following retinal vein occlusion (RVO) including branch, central and ...

Rapid drying of retinal fluid with faricimab injections may help identify patients with neovascular age-related macular degeneration who can safely extend time between injections.

Company will debut five-year results from GALE study showing meaningful impact of early and continuous treatment with SYFOVRE® (pegcetacoplan ...

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

Age-related macular degeneration (AMD) causes significant vision loss in seniors who have it. And there are many of them.

Through a series of experiments supported by the National Institutes of Health, Johns Hopkins Medicine (JHM) researchers say ...

Through a series of experiments supported by the National Institutes of Health, Johns Hopkins Medicine (JHM) researchers say they have advanced understanding of how smoking damages the eye and ...